Pentraxin 3 ELISA Kit

$1,130.00

The Pentraxin 3 ELISA Kit is intended for the quantitative determination of human Pentraxin 3 in plasma, and cell culture supernatant samples. The Pentraxin 3 ELISA Kit is for research use only and not to be used for diagnostic procedures.

Pentraxin 3 ELISA Kit

Pentraxin 3 (PTX3), also known as tumor necrosis factor-stimulated gene 14 (TSG-14), is a member of the long pentraxin family of pattern-recognition proteins involved in innate immunity and inflammatory responses. Unlike the short pentraxins C-reactive protein (CRP) and serum amyloid P-component (SAP), which are predominantly produced by the liver, PTX3 is locally synthesized by a variety of cell types, including macrophages, neutrophils, mesangial cells, synovial cells, smooth muscle cells, alveolar epithelial cells, and glial cells. Human PTX3 is a secreted glycoprotein with a molecular mass of approximately 45 kDa, consisting of a 162-amino-acid N-terminal region and a 202-amino-acid C-terminal pentraxin domain. Its expression is induced by inflammatory cytokines, particularly interleukin-1β (IL-1β) and tumor necrosis factor-alpha (TNF-α), as well as by selected pathogen-associated molecular patterns (PAMPs). PTX3 contributes to innate immune defense through pathogen recognition, complement regulation, and the clearance of apoptotic cells. Its interaction with complement component C1q is context-dependent: surface-bound PTX3 can promote classical complement pathway activation, whereas soluble PTX3 may inhibit this process.

In research settings, PTX3 is studied as an important regulator of innate immune responses, inflammation, and tissue homeostasis. Its local production by immune and structural cells allows it to reflect inflammatory processes occurring within tissues, rather than relying exclusively on hepatic production. PTX3 also contributes to the recognition and clearance of pathogens and apoptotic cells, making it relevant to investigations of host defense, complement activation, and the resolution of inflammation. Its interaction with C1q and its ability to either promote or limit classical complement activation depending on the surrounding conditions have generated interest in its role in complement-mediated inflammatory disorders and tissue injury.

In clinical research, circulating PTX3 concentrations have been investigated in a range of inflammatory, cardiovascular, autoimmune, and pregnancy-related conditions. Elevated levels have been reported in critically ill patients, with increasing concentrations observed across different stages of systemic inflammation, from systemic inflammatory response syndrome (SIRS) to septic shock. Increased PTX3 concentrations have also been associated with myocardial infarction, rheumatoid arthritis, atherosclerosis, small-vessel vasculitis, and psoriasis. Additionally, higher serum PTX3 levels have been reported in pregnancies complicated by pre-eclampsia compared with normal pregnancies. These findings support the investigation of PTX3 as a potential biomarker of inflammation, disease severity, and tissue injury. However, PTX3 is elevated across a broad range of conditions and is not disease-specific; its measurement should therefore be interpreted alongside clinical and other laboratory findings rather than as an independent diagnostic indicator.

This Pentraxin 3 ELISA Kit is manufactured in Netherlands by Hycult Biotech.

Size
Sensitivity 0.04 ng/mL
Dynamic Range 0.04 – 10 ng/mL
Incubation Time 3 hours 30 minutes
Sample Type Plasma, Cell Culture Supernatant
Storage 2-8°C
Alternative Names PTX3, Tumor necrosis factor-inducible gene 14 protein, TSG-14

 

Product Citations